Executive Summary
This period contains a single high-value federal award: an $88,992,131 firm-fixed-price delivery order to Medline Industries, LP from the Department of Veterans Affairs (SAC Frederick) for medical-surgical prime vendor expenditures for September 2026. The award is 100% civilian (0/1 defense-related), with no DOD exposure, so it carries no direct defense-sector or NDAA-alignment signal.
The dominant theme is VA medical-surgical supply distribution, and the highest-conviction takeaway is that Medline holds an established, full-and-open, non-set-aside prime vendor relationship with the VA — a modest positive for its government channel but not a new program win. The critical caveat is duration: the performance period is a single month (2026-09-01 to 2026-09-30), total obligation equals base-plus-options at $88,992,131 with no option value, and $0 has been outlayed to date, indicating a recurring monthly spend report rather than a multi-year commitment. Key watch items are whether similar monthly VA prime vendor awards recur (which would validate an annualized run-rate of roughly $1.07B) and the award-date (2026-10-28) versus start-date (2026-09-01) inconsistency.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from October 23, 2026.
Investment Signals (2)
- Medline Industries wins $88.99M VA medical-surgical prime vendor delivery order (MEDIUM)▲
Medline Industries, LP received an $88,992,131 firm-fixed-price delivery order from the Department of Veterans Affairs (SAC Frederick) for September 2026 medical-surgical prime vendor expenditures, awarded under full and open competition with no set-aside.
- Single-month performance period limits Medline award to ~$89M with no option value (HIGH)▲
Total obligation and base-plus-options are identical at $88,992,131 and the performance period runs only 2026-09-01 to 2026-09-30, so this reflects roughly one month of prime vendor spend rather than a multi-year commitment; the ~$1.07B annualized run-rate is NOT confirmed by the data.
Risk Flags (2)
- Budget [MEDIUM RISK]▼
The Medline award is a one-month VA prime vendor expenditure report with $0 outlayed to date; there is no evidence of a recurring multi-month commitment, so revenue durability is unproven from a single data point.
- Competition [LOW RISK]▼
The award was full and open competition with no set-aside and Medline is explicitly 'Not Designated a Small Business', meaning the position is contestable and not protected by set-aside policy preferences.
Opportunities (1)
- ◆
If the $88,992,131 September 2026 VA prime vendor spend recurs monthly, Medline's implied annualized VA run-rate would be approximately $1.07B, though this pattern is not confirmed by the data.
Sector Themes (1)
- ◆
An $88,992,131 monthly prime vendor expenditure report from the Department of Veterans Affairs to Medline Industries, LP evidences ongoing VA medical-surgical distribution spending, though a single data point does not establish trend direction.
Watch List (1)
- 👁
{"entity" => "Medline Industries, LP", "reason" => "Sole award this period: $88,992,131 VA delivery order with a one-month performance period and $0 outlayed to date.", "trigger" => "Recurrence of monthly VA prime vendor awards and outlay progression from $0"}
Get daily alerts with 2 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: High-Value Federal Grants ($5M+)
🇺🇸 More from United States
View all →October 24, 2026
All NASA Contracts — October 24, 2026
All NASA Contracts
October 23, 2026
US Pre-Market SEC Filings Roundup — October 23, 2026
US Pre-Market SEC Filings Roundup
October 23, 2026
S&P 500 Financials Sector SEC Filings — October 23, 2026
S&P 500 Financials Sector SEC Filings
October 23, 2026
Insider Trading Pulse — October 23, 2026
Insider Trading Pulse